Lioton (Heparin Sodium)

• Lioton (heparin sodium) is used in the management of superficial vascular conditions where local anticoagulation is required.
• Superficial thrombophlebitis: reduces clot formation and inflammation in affected veins.
• Bruising and hematoma: limits progression of bleeding into skin and soft tissue.
• Varicose vein discomfort: alleviates local swelling and pain associated with venous stasis.
• Post‑procedural site care: helps prevent clot development after minor skin surgeries or catheter insertions.

• Heparin sodium binds to antithrombin III, inducing a conformational change that markedly increases the inhibitor’s activity against serine proteases, chiefly thrombin (factor IIa) and factor Xa. By accelerating the inactivation of these key enzymes in the coagulation cascade, the drug impedes the conversion of fibrinogen to fibrin, thereby preventing the formation and propagation of clots at the site of application.

Topical heparin may cause local and systemic adverse reactions, although systemic exposure is limited.

Common Side Effects

• Skin irritation or redness at the application site.
• Itching or mild pruritus.
• Dryness or peeling of the skin.
• Mild localized pain or tenderness.
• Minor bruising or discoloration.
• Slight swelling.

Serious or Rare Side Effects

• Allergic reactions such as rash, swelling, or hives.
• Severe skin necrosis or ulceration.
• Systemic bleeding due to excessive anticoagulation.
• Heparin‑induced thrombocytopenia (HIT).
• Anaphylaxis.

• When using Lioton, consider the following safety measures.
• Assess bleeding risk: evaluate patient history for coagulopathy or anticoagulant use.
• Avoid on infected skin: do not apply to open wounds with active infection.
• Monitor for hypersensitivity: discontinue if rash or swelling develops.
• Use with caution in renal impairment: adjust monitoring as systemic absorption may increase.
• Pregnancy and lactation: consult healthcare provider before use.
• Store below 25°C: keep in original container, protect from moisture and light.

Lioton may interact with other medicines; review patient medication lists.

Major Interactions (Avoid)

• Concurrent systemic anticoagulants (e.g., warfarin, direct oral anticoagulants): risk of excessive bleeding.
• Thrombolytic agents (e.g., alteplase): additive anticoagulant effect.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) applied to same area: increased bleeding risk.

Moderate Interactions (Monitor Closely)

• Antiplatelet agents (e.g., aspirin, clopidogrel): monitor for bruising.
• Corticosteroid creams: may enhance skin thinning, affecting absorption.
• Herbal supplements with anticoagulant properties (e.g., ginkgo, garlic): advise caution.